SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028549
Filing Date
2023-08-09
Accepted
2023-08-09 16:01:02
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20230630.htm   iXBRL 10-Q 894878
2 EX-10.1 crdf-063023exhibit101.htm EX-10.1 183651
3 EX-31.1 crdf-063023exhibit311.htm EX-31.1 10716
4 EX-31.2 crdf-063023exhibit312.htm EX-31.2 10686
5 EX-32.1 crdf-063023exhibit321.htm EX-32.1 6119
6 EX-32.2 crdf-063023exhibit322.htm EX-32.2 6089
  Complete submission text file 0001628280-23-028549.txt   5176305

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230630.xsd EX-101.SCH 29655
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20230630_cal.xml EX-101.CAL 65638
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20230630_def.xml EX-101.DEF 110484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230630_lab.xml EX-101.LAB 492996
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230630_pre.xml EX-101.PRE 287768
50 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230630_htm.xml XML 771505
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 231154970
SIC: 2836 Biological Products, (No Diagnostic Substances)